ImmunityBio financial statements

이뮤니티바이오NASDAQ:IBRX · Nasdaq · Healthcare · sector #13
$10.38+0.92%
2026-10-05 close

ImmunityBio's published financial data is dated 2026-10-04. 2024 revenue was $15M. 2024 operating profit was −$344M.

Reported results

ImmunityBio notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q